Highly sensitive in vitro bioassay for Luteinizing Hormone and Chorionic Gonadotropin
IIn previous studies, we had shown the synergistic effect of 10-5 M forskolin (FSK) on the detection threshold of the cyclic AMP response to Luteinizing Hormones (LH) and Chorionic Gonadotropins (CG) from various species in the mouse Leydig Tumor cell (mLTC) cell line. Indepedently, we had started to study the effect of 10-12 – 10-6 M OXT also on the cyclic AMP response to LH and CG preparations on these same cells and found an amplifying effect on the luminescence response caused by gonadotropins. The aim was then to explore the effects of 10-12 – 10-6 M OXT on the gonadotropin-induced cAMP response, in the presence or absence of 10 µM FSK to optimize the assay down to a sensitivity compatible with the detection of the circulating concentrations of these hormones in various species. Finally the optimization relies on three independent phenomena: 1/ the inhibition of nucleotide phosphodiesterase by IBMX to avoid cAMP degradation, 2/ the strong synergy of 10 µM forskolin with low concentrations of LH or CG during the 1-hour luminescence measurement and, 3/ the stimulatory effect of 10-8M oxytocin on the amplitude of transfected cAMP-sensitive luciferase response. By doing this, the detectable concentrations are at the 1-10 pg/well (pM range) for the LHs and CGs from various species. The bioactivities of circulating LHs and CGs in blood or urine are therefore expected to be measurable in 10µL-plasma samples from mammalian species and maybe others.